Bruker (NASDAQ: BRKR) — Perfil da empresa, notícias e dados financeiros
Bruker develops high-performance scientific instruments for pharma, biotech, clinical, and industrial applications.
Bruker
Bruker is a manufacturer of high-performance scientific instruments and analytical and diagnostic solutions for life science research, materials analysis, and industrial applications. The company develops and supplies technologies including nuclear magnetic resonance spectrometers, mass spectrometry systems, X-ray diffraction and fluorescence analyzers, atomic force microscopes, fluorescence optical microscopy platforms, and high-temperature superconducting wire products. Its instruments enable academic institutions, pharmaceutical and biotechnology companies, clinical diagnostic laboratories, and semiconductor manufacturers to perform structural biology research, cellular imaging, chemical characterization, and quality control.
Resumo
Operações
Produtos e/ou serviços de Bruker
- Nuclear Magnetic Resonance Spectrometers: Development and production of ultra-high field NMR systems, EPR instruments, and preclinical imaging systems, including 1.3 GHz spectrometers, serving structural biology, chemistry, and materials science research institutes and university facilities globally.
- Mass Spectrometry Systems: Supply of timsTOF liquid chromatography mass spectrometers, MALDI-TOF systems, and FT-ICR instruments for proteomics, metabolomics, lipidomics, and clinical diagnostics across pharmaceutical, biopharmaceutical, clinical diagnostic, and academic research laboratories worldwide.
- X-Ray and Elemental Analysis Systems: Manufacture of X-ray diffraction, X-ray fluorescence, and energy-dispersive spectroscopy systems, such as S8 TIGER spectrometers and XFlash detectors, used for elemental identification, structural determination, and quality control in industrial facilities.
- Surface Analysis and Atomic Force Microscopes: Provision of atomic force microscopes, 3D optical profilometers, and nanomechanical testing instruments used in semiconductor characterization, 2D materials research, and advanced surface metrology across microelectronics and nanotechnology research facilities worldwide.
- Fluorescence Microscopy and Spatial Biology: Delivery of multiphoton, light-sheet, and super-resolution fluorescence microscopy platforms, single-cell spatial biology systems, and tissue-clearing imaging workflows for neuroscience, immunology, and oncology research across biomedical institutes globally.
- Superconducting Materials and Energy Products: Production of low-temperature and high-temperature superconducting wires, stranded conductors, and specialized magnet components utilized in magnetic confinement fusion power projects, nuclear magnetic resonance, and medical magnetic resonance imaging scanners globally.
equipe executiva do Bruker
- Frank H. LaukienChairman, CEO & President
- Gerald N. HermanExecutive VP & CFO
- Mark R. MunchCorporate Executive VP and President of Bruker Nano Group & Corporate
- Juergen W. SregaPresident of Bruker Biosystems Group & Bruker Daltonics Division
- Thomas M. BuresChief Accounting Officer
- J. Brent AlldredgeSenior VP, General Counsel, Secretary & Global Head of Compliance
- Wolfgang PuschPresident of Bruker Microbiology & Infection Diagnostics Group
- Burkhard PrausePresident and CEO of Bruker Energy & Supercon Technologies, Inc.
Histórico de dividendos
Dividendos por ação pagos pela Bruker , por ano fiscal.
| Ano fiscal | Intermediário | Final | Especial | Total |
|---|---|---|---|---|
| FY2026(até o momento) | — | — | — | $0.1500 |
| FY2025 | — | — | — | $0.2000 |
| FY2024 | — | — | — | $0.2000 |
| FY2023 | — | — | — | $0.2000 |
| FY2022 | — | — | — | $0.2000 |
Principais indicadores financeiros
Resultados divulgados pela Bruker , em USD.
- Cap. de mercado
- 10,2 bi
- Receita (TTM)
- 3,5 bi
- P/L
- —
- LPA (diluído, TTM)
- -1.1
- Dividend yield
- 0.1%
- Margem de lucro
- -3.5%
| Fim do ano fiscal | Receita | Resultado operacional | Lucro líquido |
|---|---|---|---|
| 3,4 bi | 236 mi | -8,6 mi | |
| 3,4 bi | 253,1 mi | 113,1 mi | |
| 3 bi | 436,9 mi | 427,2 mi | |
| 2,5 bi | 432,7 mi | 296,6 mi |